Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04067115
Title SARC037: A Phase I Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients (U01CA236220)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sarcoma Alliance for Research through Collaboration

Ewing sarcoma


Irinotecan + Trabectedin

Age Groups: child | senior | adult
Covered Countries USA

No variant requirements are available.